Eli Lilly to buy bowel disease drug developer Morphic for $3.2bn
Eli Lilly to acquire Morphic Holding companies said Monday that for $3.2 billion in cash, they will give the U.S. drugmaker access to an experimental drug to treat various inflammatory bowel diseases.
ENTRADAS POPULARES
UK sets new climate target for 2035
noviembre 13, 2024
Children go back to school after Valencia floods
noviembre 13, 2024
Researchers document huge decline in African elephants
noviembre 13, 2024
Mission: Impossible 8 title revealed
noviembre 13, 2024
TRANSMISIÓN EN VIVO